Arrowhead Pharmaceuticals, Inc. today announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company's investigational RNA interference (RNAi) therapeutic designed to ...

Arrowhead Pharmaceuticals’ phase 1/2a study has found the company’s investigational RNA interference (RNAi) candidate was ...

H.C. Wainwright reiterates a Buy rating and $80 price target on shares of Arrowhead (ARWR) Pharmaceuticals after the company announced top-line ...

Arrowhead (ARWR) announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference ...

Discover how your body and mind adapt when sexual activity stops, from changing desire patterns to unexpected effects on your ...

In the United States, Irish whiskey has long been overshadowed by bourbon and Scotch whisky. Where those styles have enjoyed ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...

Discover how laughter naturally improves lung health by enhancing oxygen flow, clearing airways, and boosting respiratory ...

Odd Burger Corporation ("Odd Burger" or the "Company") , a leading vegan fast-food restaurant chain and food technology company, is pleased to detail its U.S. expansion strategy amid recent tariffs on ...

Secretory IgA is resistant to degradation and provides ... Postnatal maternal immunizations aimed to enhance breast milk antibodies production might be a promising approach. In addition to being ...

XYNGARI� Phase 3 STAR-1 trial enrolled 520 patients with moderate-to-severe acne in the U.S. and Latin America - SAN DIEGO, March 4, 2025 /PRNewswire/ -- Dermata Therapeutics, Inc. (Nasdaq: DRMA, ...

So what does your choice of uni say about you? Do people think you’re elite, edgy or just plain annoying thanks to your ...